Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancers.
Campbell MR, Ruiz-Saenz A, Peterson E, Agnew C, Ayaz P, Garfinkle S, Littlefield P, Steri V, Oeffinger J, Sampang M, Shan Y, Shaw DE, Jura N, Moasser MM.
Campbell MR, et al. Among authors: agnew c.
Cell Rep. 2022 Feb 1;38(5):110291. doi: 10.1016/j.celrep.2021.110291.
Cell Rep. 2022.
PMID: 35108525
Free PMC article.